Regulatory Issues

  • Letter Regarding Meeting with Palmetto GBA J-1 Contractor Medical Directors

    September 17, 2010
      September 17, 2010 Mr. Michael Barlow Vice President, Medicare Operations Palmetto GBA 4249 Easter Way Columbus, OH 43219 Dear Mr. Barlow: On behalf of the members of the American Clinical Laboratory Association (ACLA), I am writing to seek a meeting with you and the Palmetto GBA J-1 contractor medical directors to discuss our concerns about Palmetto’s recently announced plans to launch the CMSContinue Reading »...
  • Comments on Modifications to HIPAA Privacy Comments

    September 13, 2010
      September 13, 2010 The American Clinical Laboratory Association (ACLA) is pleased to have this opportunity to submit our comments on the Modifications to the HIPAA Privacy, Security, and Enforcement Rules Under the Health Information Technology for Economic and Clinical Health Act; Proposed Rule (the “Proposed Rule”) issued by the Office for Civil Rights (OCR). ACLA is an association representing clinical laboratories throughout the country, inclucgContinue Reading »...
  • Comments Regarding Proposed NIH Genetic Test Registry

    July 29, 2010
    Re: Request for Information on the National Institutes of Health Plan to Develop a Genetic Testing Registry Dear Dr. Collins: On behalf of the American Clinical Laboratory Association (ACLA), I am pleased to submit these comments on the proposed National Institutes of Health (NIH) Genetic Test Registry (GTR). ACLA represents national, regional, and local laboratories across the country, many of which offer extensive menusContinue Reading »...
  • Comments on NPI Interim Final Rule

    June 07, 2010
    Acting Administrator Marilyn Tavenner Centers for Medicare & Medicaid Services Department of Health and Human Services Room 445-G Hubert H. Humphrey Building 200 Independence Avenue, SW Washington, DC 20201   RE: Medicare and Medicaid Programs; Changes in Provider and Supplier Enrollment, Ordering and Referring, and Documentation Requirements; and Changes in Provider Agreements (CMS-6010-IFC) Dear Acting Administrator Tavenner: On behalf of the American Clinical LaboratoryContinue Reading »...
1 2 3 4 5 6 7